UNSPSC 51283516: Oxacillin sodium

This classification denotes an anti-bacterial agent with the molecular formula C19H18N3O5S.Na.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G0V6C994Q5, chemically known as 5-methyl-3-phenyl-4-isoxazolyl penicillin, sodium but more generally known as oxacillin sodium, which bears US NIH Compound Identifier 4608. European Medicines Agency schedules Oxacillin sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03559MIG.

Most nations, for tariff and trade purposes, schedule oxacillin sodium under HS 29411090 and SITC 54131. As of Q4 2014, OXACILLIN SODIUM remains US FDA's Preferred Term for this commodity. Oxacillin sodium bears US NLM identifiers UMLS ID C0037536 and NCI Concept Code C720. SMILES: CC1C(C(NO1)C2CCCCC2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-].O.[NA+].

UNSPSC 51283516 Oxacillin sodium is a Commodity code that covers antibiotic pharmaceutical products, though the recent state and local contract opportunities indexed under this code show minimal direct alignment with oxacillin procurement. Instead, the opportunities reflect broader pharmaceutical acquisition and emergency-response medical supply sourcing through established cooperative purchasing vehicles and county procurement processes. State and local governments use codes in this family to stock injectable and oral antibiotics for public health programs, emergency preparedness, and community health initiatives, typically via piggyback agreements, consortial purchasing, or competitive sealed bidding. Issuing bodies include state health departments, county health systems, and county emergency management offices operating under fixed-term contracts with annual renewal options.

Recent activity shows limited volume indexed to this specific code. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026, covering Doxycycline Hyclate and Ciprofloxacin Hydrochloride (antibiotic classes distinct from oxacillin) under an Invitation for Bid with a 12-month term and two renewal options. Seminole County, Florida released an IFB on June 30, 2026, for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries, though this procurement falls outside antibiotic pharmaceutical scope and reflects emergency-response supply acquisition rather than oxacillin-specific demand. The code shows activity in Florida and Illinois, with procurement structured through county e-procurement portals and state health department cooperative agreements. No recent open solicitations specifically targeting oxacillin sodium are present in the opportunity block; the code warrants continued monitoring for state pharmaceutical stockpiling or emergency-response RFPs.